Preparing your results

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial.

OBJECTIVES: We examined the effectiveness of risk reduction counseling and the role of on-site HIV testing in drug treatment. METHODS: Between January and May 2009, we randomized 1281 HIV-negative (or status unknown) adults who reported no past-year HIV testing to (1) referral for off-site HIV testing, (2) HIV risk-reduction counseling with on-site rapid HIV testing, or (3) verbal information about testing only with on-site rapid HIV testing. RESULTS: We defined 2 primary self-reported outcomes a priori: receipt of HIV test results and unprotected anal or vaginal intercourse episodes at 6-month follow-up. The combined on-site rapid testing participants received more HIV test results than off-site testing referral participants (P<.001; Mantel-Haenszel risk ratio=4.52; 97.5% confidence interval [CI]=3.57, 5.72). At 6 months, there were no significant differences in unprotected intercourse episodes between the combined on-site testing arms and the referral arm (P=.39; incidence rate ratio [IRR]=1.04; 97.5% CI=0.95, 1.14) or the 2 on-site testing arms (P=.81; IRR=1.03; 97.5% CI=0.84, 1.26). CONCLUSIONS: This study demonstrated on-site rapid HIV testing's value in drug treatment centers and found no additional benefit from HIV sexual risk-reduction counseling.

Pubmed ID: 22515871

Authors

  • Metsch LR
  • Feaster DJ
  • Gooden L
  • Matheson T
  • Mandler RN
  • Haynes L
  • Tross S
  • Kyle T
  • Gallup D
  • Kosinski AS
  • Douaihy A
  • Schackman BR
  • Das M
  • Lindblad R
  • Erickson S
  • Korthuis PT
  • Martino S
  • Sorensen JL
  • Szapocznik J
  • Walensky R
  • Branson B
  • Colfax GN

Journal

American journal of public health

Publication Data

June 10, 2012

Associated Grants

  • Agency: NIDA NIH HHS, Id: HHSN271200522071C
  • Agency: PHS HHS, Id: HHSN271200522071C
  • Agency: PHS HHS, Id: HHSN271200522081C
  • Agency: NIDA NIH HHS, Id: K23 DA019809
  • Agency: NIAID NIH HHS, Id: P30 AI060354
  • Agency: NIDA NIH HHS, Id: U10 DA013034
  • Agency: NIDA NIH HHS, Id: U10 DA013036
  • Agency: NIDA NIH HHS, Id: U10 DA013038
  • Agency: NIDA NIH HHS, Id: U10 DA013720
  • Agency: NIDA NIH HHS, Id: U10 DA013727
  • Agency: NIDA NIH HHS, Id: U10 DA013732
  • Agency: NIDA NIH HHS, Id: U10 DA015815
  • Agency: NIDA NIH HHS, Id: U10 DA015833
  • Agency: NIDA NIH HHS, Id: U10 DA020036
  • Agency: NIDA NIH HHS, Id: U10DA013038
  • Agency: NIDA NIH HHS, Id: U10DA013720
  • Agency: NIDA NIH HHS, Id: U10DA013732
  • Agency: NIDA NIH HHS, Id: U10DA015833
  • Agency: NIDA NIH HHS, Id: U10DA020036
  • Agency: NIDA NIH HHS, Id: U10DA13034
  • Agency: NIDA NIH HHS, Id: U10DA13036
  • Agency: NIDA NIH HHS, Id: U10DA13720-09S
  • Agency: NIDA NIH HHS, Id: U10DA13727
  • Agency: NIDA NIH HHS, Id: U10DA15815
  • Agency: NIDA NIH HHS, Id: UG1 DA015815

Mesh Terms

  • Adult
  • Counseling
  • Female
  • Follow-Up Studies
  • HIV
  • HIV Infections
  • Humans
  • Male
  • Mass Screening
  • Middle Aged
  • Program Evaluation
  • Risk Reduction Behavior
  • Substance Abuse Treatment Centers
  • United States
  • Unsafe Sex